Open AccessSuccessful antiviral therapy is associated with a decrease of serum prohepcidin in chronic hepatitis C
Author(s) -
Jerzy Jaroszewicz,
Magdalena Rogalska,
Iwona Flisiak,
Robert Flisiak
Publication year - 2010
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v16.i14.1747
Subject(s) - medicine , ribavirin , pegylated interferon , gastroenterology , chronic hepatitis , hepatitis c , hepatitis c virus , antiviral therapy , hepacivirus , immunology , virus
To assess serum concentrations of prohepcidin in chronic hepatitis C individuals and evaluate their associations with disease activity and efficacy of pegylated interferon (PEG-IFN)/ribavirin (RBV) therapy.